BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 31636099)

  • 1. Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.
    Murga-Zamalloa C; Rolland DCM; Polk A; Wolfe A; Dewar H; Chowdhury P; Onder O; Dewar R; Brown NA; Bailey NG; Inamdar K; Lim MS; Elenitoba-Johnson KSJ; Wilcox RA
    Clin Cancer Res; 2020 Feb; 26(3):690-703. PubMed ID: 31636099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
    Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
    Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF1/CSF1R-mediated Crosstalk Between Choroidal Vascular Endothelial Cells and Macrophages Promotes Choroidal Neovascularization.
    Zhou Y; Zeng J; Tu Y; Li L; Du S; Zhu L; Cang X; Lu J; Zhu M; Liu X
    Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):37. PubMed ID: 33764399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma.
    Smeester BA; Slipek NJ; Pomeroy EJ; Laoharawee K; Osum SH; Larsson AT; Williams KB; Stratton N; Yamamoto K; Peterson JJ; Rathe SK; Mills LJ; Hudson WA; Crosby MR; Wang M; Rahrmann EP; Moriarity BS; Largaespada DA
    Bone; 2020 Jul; 136():115353. PubMed ID: 32251854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.
    Okugawa Y; Toiyama Y; Ichikawa T; Kawamura M; Yasuda H; Fujikawa H; Saigusa S; Ohi M; Araki T; Tanaka K; Inoue Y; Tanaka M; Miki C; Kusunoki M
    Int J Oncol; 2018 Aug; 53(2):737-749. PubMed ID: 29767252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas.
    Bhatt AP; Bhende PM; Sin SH; Roy D; Dittmer DP; Damania B
    Blood; 2010 Jun; 115(22):4455-63. PubMed ID: 20299510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression and activation of colony-stimulating factor 1 receptor in the SIV/macaque model of HIV infection and neuroHIV.
    Irons DL; Meinhardt T; Allers C; Kuroda MJ; Kim WK
    Brain Pathol; 2019 Nov; 29(6):826-836. PubMed ID: 31033097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy.
    Gyori D; Lim EL; Grant FM; Spensberger D; Roychoudhuri R; Shuttleworth SJ; Okkenhaug K; Stephens LR; Hawkins PT
    JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF1/CSF1R signaling mediates malignant pleural effusion formation.
    Kosti CN; Vaitsi PC; Pappas AG; Iliopoulou MP; Psarra KK; Magkouta SF; Kalomenidis IT
    JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-148b-colony-stimulating factor-1 signaling-induced tumor-associated macrophage infiltration promotes hepatocellular carcinoma metastasis.
    Ke M; Zhang Z; Cong L; Zhao S; Li Y; Wang X; Lv Y; Zhu Y; Dong J
    Biomed Pharmacother; 2019 Dec; 120():109523. PubMed ID: 31655310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CSF1-CSF1R pathway in the trigeminal ganglion mediates trigeminal neuralgia via inflammatory responses in mice.
    He Z; Xu C; Guo J; Liu T; Zhang Y; Feng Y
    Mol Biol Rep; 2024 Jan; 51(1):215. PubMed ID: 38281257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model.
    Tahmasebi F; Pasbakhsh P; Mortezaee K; Madadi S; Barati S; Kashani IR
    J Cell Biochem; 2019 Jun; 120(6):10576-10586. PubMed ID: 30628737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Properties of JTE-952, an Orally Available and Selective Colony Stimulating Factor 1 Receptor Kinase Inhibitor.
    Uesato N; Miyagawa N; Inagaki K; Kakefuda R; Kitagawa Y; Matsuo Y; Yamaguchi T; Hata T; Ikegashira K; Matsushita M
    Biol Pharm Bull; 2020; 43(2):325-333. PubMed ID: 32009119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Pyrrolo[2,3-d]pyrimidine derivatives as potent and selective colony stimulating factor 1 receptor kinase inhibitors.
    Liang X; Wang C; Wang B; Liu J; Qi S; Wang A; Liu Q; Deng M; Wang L; Liu J; Liu Q
    Eur J Med Chem; 2022 Dec; 243():114782. PubMed ID: 36179404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of a pexidartinib bioisostere inhibiting CSF1 production and CSF1R kinase activity in human hepatocellular carcinoma.
    Awasthi BP; Guragain D; Chaudhary P; Jee JG; Kim JA; Jeong BS
    Chem Biol Interact; 2023 Jan; 369():110255. PubMed ID: 36368339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of CSF1R and KIT With Pexidartinib Reduces Inflammatory Signaling and Cell Viability in Endometriosis.
    Dunn TN; Cope DI; Tang S; Sirupangi T; Parks SE; Liao Z; Yuan F; Creighton CJ; Masand RP; Alpuing Radilla L; Guan X; Detti L; Monsivais D; Matzuk MM
    Endocrinology; 2024 Feb; 165(4):. PubMed ID: 38227801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options.
    Quesada AE; Nguyen ND; Rios A; Brown RE
    Int J Clin Exp Pathol; 2014; 7(12):8732-9. PubMed ID: 25674239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early posttraumatic CSF1R inhibition via PLX3397 leads to time- and sex-dependent effects on inflammation and neuronal maintenance after traumatic brain injury in mice.
    Wang Y; Wernersbach I; Strehle J; Li S; Appel D; Klein M; Ritter K; Hummel R; Tegeder I; Schäfer MKE
    Brain Behav Immun; 2022 Nov; 106():49-66. PubMed ID: 35933030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas.
    Gao X; Kady N; Wang C; Abdelrahman S; Gann P; Sverdlov M; Wolfe A; Brown N; Reneau J; Robida AM; Murga-Zamalloa C; Wilcox RA
    Cancer Res Commun; 2022 Dec; 2(12):1727-1737. PubMed ID: 36970721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.